Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

Ashfield bolsters leadership team with two new hires

Beverley Gall and Tony Woods join as performance directors

- PMLiVE

GSK’s R&D head Vallance departs, possibly for government role

An independent panel of scientists proposed the UK role to Vallance, according to the FT

(Left to right) Brian Parsons, Jon Hallows, Gordon Muir-Jones, Kevin Ryder

Porterhouse Medical announces expansion into the US

  6 November 2017; Reading, UK – UK-based Porterhouse Medical Ltd is delighted to announce the opening of a subsidiary in Philadelphia, PA, USA. The new entity, Porterhouse Medical US, is...

Porterhouse Medical Group

Pharma’s digital patient engagement innovators identified

Novartis, Pfizer and Sanofi named best-in-class by Decision Resources Group

- PMLiVE

Exploring serious market access roadblocks for rare bleeding disorders

Ensuring that sufferers get the treatment they require

- PMLiVE

Boehringer bolsters NASH pipeline with $201m Dicerna deal

Will investigate a “new therapeutic approach” to target liver functionality

Roche Basel Switzerland

Smartphone monitoring shows its worth in Roche MS trial

The tool uses smartphone sensors to measure neurological tests

Esteve appoints Albert Esteve as chairman of the board of directors

He succeeds Joan Esteve, who continues as chairman of the general shareholders meeting

Topas Therapeutics appoints chief development officer and chief medical officer

Rupert Sandbrink joins from Forward Pharma

- PMLiVE

Gene therapy

When will it deliver?

- PMLiVE

Parexel enhances its clinical supplies mobile app

Adds Bluetooth capability to better monitor temperature-sensitive medication

- PMLiVE

FDA panel backs Indivior’s drug to fight opioid addiction

The former RB pharma unit hopes for sales in the $1bn region

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links